Cumberland Pharmaceuticals Inc: Form 8-K, filed Nov 16, 2018
Filed with the SEC on Nov 16, 2018 and accepted by EDGAR at Nov 16, 2018, 17:12 ET.
Items reported
- Item 2.01 Completion of an acquisition or disposition
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001628280-18-014467. Last ingested by Listed: Nov 11, 2026, 03:05 ET. Listed shows no prices and gives no investment advice.